Monday, May 7, 2007

CollaGenex discontinues treating patients in 40 mg arm of trial

(Reuters) - In a statement, the company said it learned of another case of apparent photo-toxicity, a side effect that was also observed last Wednesday in one patient.




Read more at Reuters.com Government Filings News

No comments: